Search results
Author(s):
Robert F Storey
Added:
1 year ago
Author(s):
Luca Paolucci
,
Asad Shabbir
,
Marco Lombardi
,
et al
Added:
10 months ago
Author(s):
Arditya Damarkusuma
,
Paula Mota
,
Billal Patel
,
et al
Added:
1 year ago
Author(s):
Mohamed Marwan
Added:
2 months ago
Explore the evolving paradigm of lifetime management in TAVI with Dr Mohamed MarwanThis presentation addresses the critical shift from single-procedure focus to comprehensive lifetime planning in TAVI management. As guidelines expand to include patients as young as 65 years old, Dr Marwan examines the unique considerations that arise when treating more active individuals who may require future…
View more
Author(s):
Alfonso Ielasi
Added:
2 years ago
This video features Dr Alfonso Ielasi (IRCCS Ospedale Galeazzi Sant'Ambrogio, Milano, IT) presenting a dynamic poster focused on the 2-Year Follow-up of a Hybrid Strategy for Diffuse Coronary Artery Disease (CAD).He highlights the challenging nature of de novo diffuse coronary artery disease (CAD) in interventional cardiology, where limited treatment options exist beyond stent implantation.To…
View more
Author(s):
Arditya Damarkusuma
Added:
1 year ago
In this video, Dr Arditya Damarkusuma (Universitas Gadjah Mada, ID) presents his case report on aorto-ostial lesions, recently published in ICR Journal.This case covers the restenosis of a markedly protruding stent at the right coronary ostium in a 54-year old man, and is unusual in its 10-year longevity. Intravascular ultrasound-guided in-stent restenosis intervention using a wire bumper…
View more
Author(s):
Nicolas M Van Mieghem
,
David Hildick-Smith
,
Roxana Mehran
,
et al
Start date:
Apr 10, 2025
Author(s):
Jacob Thomsen Lønborg
Added:
5 months ago
EuroPCR 25 - 10-year follow-up findings of DANAMI-3-DEFER show a deferred stenting strategy may reduce HF hospitalisation in ST-elevation myocardial infarction (STEMI) patients.We are joined by Dr Jacob Lønborg (Rigshospitalet, Copenhagen, DK) to discuss key findings from the 10-year follow-up of the DANAMI-3-DEFER (NCT01435408) trial. This randomized controlled trial compared deferred stent…
View more
Author(s):
Marianne Brodmann
Added:
1 month ago
CIRSE Congress 2025 - 24-month results show the Biotronik Dynetic-35 cobalt chromium balloon-expandable stent was safe and effective in iliac arteries.Prof Marianne Brodmann (Medical University of Graz, Graz, AT) joins us to discuss 24-month findings from BIONETIC-I (NCT04830228). The prospective, international, multi-center, single-arm study aimed to investigate the safety and effectiveness of…
View more
Added:
3 months ago
Source:
Radcliffe Cardiology
AUTHOR: Greg GuilloryThe selection of drug-eluting stents (DES) for percutaneous coronary intervention (PCI) involves balancing efficacy against safety. The SORT OUT XI randomised trial aimed to compare a newer-generation biolimus-eluting stent with a contemporary dual-therapy sirolimus-eluting stent in a real-world patient population, providing crucial head-to-head evidence.¹SORT OUT XI was a…
View more